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Aims: This study was conducted as a feasibility pilot for the Risk stratification Of Syncope in the Emergency
department (ROSE) study. The secondary aim was to compare the performance of our existing emergency
department (ED) guidelines with existing clinical decision rules (Osservatorio Epidemiologico sulla Sincope
nel Lazio (OESIL) Score and San Francisco Syncope Rule; SFSR) at predicting short-term (1 week and
1 month) and medium-term (3 months) serious outcomes for patients with syncope presenting to the ED.
Methods: This was a prospective cohort study. All patients presenting with syncope aged >16 years between
7 November 2005 and 7 February 2006 were prospectively enrolled.
Results: 99 patients were recruited over a 3-month period. 44 patients were admitted and 55 discharged
from the ED. 11 patients had a serious outcome: 8 by 7 days and a further 3 by 3 months. Five patients died
by 3 months and six others had an alternative serious outcome. All 11 patients had been admitted from the
ED, 7 were at high risk, 4 were at medium risk and none were at low risk according to our existing ED
guidelines. Percentages of serious outcomes were 0%, 2.9%, 8.0%, 22.7% and 37.5% for OESIL scores of 0,
1, 2, 3 and 4 respectively. 40 patients had none of the 5 SFSR high-risk factors (0 serious outcomes = 0%) and
59 patients had an SFSR high-risk factor (11 serious outcomes = 18.6%). The risk of serious outcome at
7 days, 1 month and 3 months was 8.1%, 8.1% and 11.1%, respectively.
Conclusions: A study to derive and validate a UK ED syncope clinical decision rule is feasible. This pilot study
has evaluated the OESIL score, the SFSR and our existing ED guidelines, and has shown that each is able to
identify an increased probability of medium-term serious outcome in patients with syncope. The SFSR shows
good sensitivity at the expense of an increase in admissions to hospital; however, our existing ED syncope
guidelines and the OESIL Score, although being able to successfully risk stratify patients, are not sufficiently
sensitive to be able to reduce admissions without missing patients at risk of a serious outcome. Undoubtedly
there is a need for a simple UK-derived clinical decision rule for patients presenting with syncope to enable
safe, effective clinical care and to aid less experienced decision makers.
S
yncope is a transient loss of consciousness with an
inability to maintain postural tone followed by a sponta-
neous recovery.1 It accounts for 3% of emergency depart-
ment (ED) visits and 1–6% of hospital medical admissions,
affecting 6 per 1000 people per year.2 3 Clinical assessment of
syncope is difficult owing to the heterogeneous nature of
underlying causes, ranging from benign neurocardiogenic
syncope to potentially fatal arrhythmias.
In 1983, Kapoor et al4 published the first prospective syncope
study. The 12-month mortality was 14%. Mortality was greatest
in patients in whom a cardiovascular cause was identified
(30%). Subsequent studies have shown that underlying heart
disease in patients with syncope is associated with a poor
prognosis.5 Recent emphasis has focused on risk stratification
of patients with syncope. Although guidelines have been
issued,6–10 evidence with respect to ED management is sparse.
There are five risk stratification studies.11–16 All involved small
numbers of patients and used different characteristics and
outcome measures in their risk stratification tools. Only one
study, US-based, looked at short-term adverse outcome,15 16
which is relevant to emergency medicine practice. No studies
have been examined in a UK population.
With growing pressures on acute medical beds and an
increasingly elderly population, a large study of this common
presenting symptom is needed to identify high-risk populations
requiring further investigation and low-risk patients who may
be discharged safely. Accurate identification of patients would
enable specific targeting of resources and prevent excessive
investigation of patients with benign causes.
This study was conducted as a pilot for the Risk stratification
Of Syncope in the Emergency department (ROSE) study. The
primary aim was to demonstrate the feasibility of study
recruitment and to test the study method before the main
ROSE study. The secondary aim was to compare the perfor-
mance of existing clinical decision rule (CDRs; The Osservatorio
Epidemiologico sulla Sincope nel Lazio (OESIL) score and San
Francisco Syncope Rule (SFSR)) with our existing departmen-
tal syncope guidelines (based on the European Society of
Cardiology,9 10 the American College of Physicians (ACP)6 7 and
the American College of Emergency Physicians guidelines8;
table 1) to predict short-term (7 days and 1 month) and
medium-term (3 month) serious outcomes for patients with
syncope presenting to a UK ED.
Abbreviations: ACP, American College of Physicians; CDR, clinical
decision rule; ED, emergency department; EPR, electronic patient record;
ROSE, Risk stratification Of Syncope in the Emergency department; OESIL,
Osservatorio Epidemiologico sulla Sincope nel Lazio; SFSR, San Francisco
Syncope Rule
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METHODS
Setting
The ED of the Royal Infirmary of Edinburgh, UK (85 000 adult
attendances per annum).
Inclusion criteria
All patients presenting with syncope aged >16 years between 7
November 2005 and 7 February 2006 were prospectively
enrolled into the study.
Exclusion criteria
Patients aged ,16 years, those previously recruited and those
with a history of seizure with prolonged post-ictal phase were
excluded. Patients who were unable to give either written or
verbal informed consent were also excluded.
Enrolment into study
ED nurses identified potentially eligible patients and a data
collection form was placed with the patient’s records. The treating
doctor was responsible for deciding whether the patient had had
an episode of syncope after the initial assessment. All doctors
involved in the study had undergone a 15-min training session on
criteria associated with a diagnosis of syncope. A decision to enrol
a patient was not overturned later by the study team and enrolled
patients were analysed on an intention-to-treat basis. The study
team reviewed the notes of any patient who had been initially
flagged by the triage nurse, but later rejected by the doctor. Only
nine patients were rejected in this manner. Reasons for the doctor
rejecting a patient were inability to obtain consent, patients being
found collapsed for an unknown period of time or patients
presenting with a likely seizure.
Assessment
All patients underwent a standardised assessment using 31
predetermined variables (11 focused on clinical features, 9 on
medical history and 11 on current medication), 28 examination
variables and 26 ECG variables. These were selected after careful
systematic review of the literature to identify characteristics
previously shown to be associated with serious outcome. After a
full history and examination, all patients underwent a 12-lead
ECG, lying and standing blood pressures were recorded and a
‘‘BM stix’’ glucose estimation. Patients who were at medium or
high risk according to our ED’s existing syncope guidelines also
had full blood count, urea, creatinine, glucose, electrolytes and C
reactive protein measured. Patients still in the ED at 12 h were
defined as admitted. Patients were admitted, referred to medical
outpatient departments or discharged according to our ED’s
existing syncope guidelines, and a study information form was
completed. Patients admitted to the hospital or who attended the
medical outpatient department underwent evaluations for any
clinical or historical findings suggestive of a cause of syncope at
the discretion of the treating consultant, including 24-h ECG tape
and echocardiography investigations.
Endpoint measures
Primary end point was a serious outcome at 1 week, 1 month
and 3 months. Serious outcomes were predefined and were
all-cause death, acute myocardial infarction (history of chest
Table 1 Our emergency department’s existing syncope guidelines based on the European
Society of Cardiology,9 10 American College of Physicians6 7 and American College of
Emergency Physicians guidelines8
High risk (admit)
Medium risk (consider discharge with early outpatient
review)
History findings
Palpitations related to syncope Age .60 years
Associated chest pain No prodromal symptoms
Associated headache Previous myocardial infarct
Related to exertion Known history of valvular heart disease
Family history of sudden death at ,60 years Known angina/coronary artery disease
Previous history of VT/VF/cardiac arrest Known history of congestive cardiac failure
Examination findings
Systolic heart murmur heard .20 mm Hg drop on standing
Signs of heart failure present Diastolic heart murmur heard
Systolic BP ,90 mm Hg Ventricular pause .3 s on carotid sinus massage
Suspicion of pulmonary
embolism
Trauma associated with collapse
AAA detected
New neurological signs on examination
Suspicion of CVA or SAH
FOB present on PR
Other suspicions of GI bleed
ECG findings
Mobitz type II heart block Right bundle branch block
Wenkebach heart block QRS duration .120ms
Bifascicular block Old T wave/ST segment changes
Complete heart block Frequent pre-excited QRC complexes
Sinus pause .3 s Q waves unchanged from old ECG
New ST elevation ventricular tachycardia Atrial fibrillation or flutter
Sinus bradycardia ,50 PR .200 ms (first-degree heart block)
Sinoatrial block
QTc .450 ms Low risk (consider discharge)
NEW T wave/ST segment changes None of the above characteristics
Brugadas (ST segment elevation V1–V3)
Arrhythmogenic right ventricular dysplasia
AAA, abdominal aortic aneurysm; BP, blood pressure; CVA, cerebrovascular accident; FOB, faecal occult blood; GI,
gastrointestinal; PR, rectal examination; SAH, subarachnoid haemorrhage; VF, ventricular fibrillation; VT, ventricular
tachycardia.
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pain or ECG changes and troponin I .2), life-threatening
arrhythmia (documented on monitor or ECG during inpatient
stay or on outpatient Holter monitoring and requiring treat-
ment), pulmonary embolus (confirmed on ventilation perfusion
lung scan/CT pulmonary angiography and requiring treatment),
cerebrovascular accident/subarachnoid haemorrhage (CT or
lumbar puncture diagnosis), haemorrhage requiring a blood
transfusion of two units or more during inpatient stay and an
acute surgical procedure or endoscopic intervention secondary
to a suspected cause of syncope.
Once 3 months had elapsed after ED attendance for all
patients, the hospital computer system was interrogated to see
whether the patients had returned to any hospital in the Lothian
region. The hospital records were acquired and scrutinised for all
patients who had attended the ED or outpatient department or
who had been admitted as inpatients. All deceased patients were
identified via the hospital computer system, which is directly
linked with the national death register and primary care patient
records. Hospital notes were scrutinised to determine whether
each patient with syncope had had a serious outcome within
3 months of their attendance to the ED. All patients could be
followed up, and all hospital notes and records could be traced.
For any patient residing outside the Lothian region, either their
general practitioner or the patient was contacted.
The presence or absence of an SFSR high-risk factor and the
patient’s OESIL score was determined by the study team from
specifically prospectively acquired information on the data
collection form. The OESIL score is based on four character-
istics: age .65 years, a clinical history of cardiovascular
disease, syncope without prodromal symptoms and an abnor-
mal ECG. The presence of each characteristic scores one. One-
year mortality has been shown to increase with increasing
score.13 The SFSR defines high-risk patients as those having any
one of the five risk factors: abnormal ECG (non-sinus rhythm
or new abnormality), anaemia (haematocrit ,30%), a com-
plaint of shortness of breath, systolic hypotension (,90 mm
Hg) and a history of congestive cardiac failure.15 16 The patient’s
ED guideline risk group (high, medium and low) was
determined by the study doctor after an initial assessment.
Review of missed patients
To determine the recruitment rate of patients into the study, a
retrospective search of all ED electronic patient records (EPRs)
between 7 November 2005 and 7 February 2006 was conducted
looking for the keywords ‘‘syncope’’, ‘‘collapse’’, ‘‘faint’’, ‘‘loss
of consciousness’’ or ‘‘loc’’ appearing anywhere on the EPR. All
EPRs with one of these terms were then hand searched and a
decision was made from the notes whether the patient fitted
the study’s inclusion criteria. A list was compiled of all patients
who fitted the study inclusion criteria, along with their
demographic details, and compared using Chi-squared and
Mann-Whithey U tests with those patients who had been
enrolled into the study.
Statistical analysis
All patient data were entered into a specially designed
Microsoft Access database and exported into Excel for
statistical analysis. A power calculation was not performed for
the pilot study; however, it was decided that 100 patients would
be sufficient for the primary aim. Sensitivity, specificity,
predictive values and likelihood ratios were calculated for
existing CDRs, current ED guidelines and some selected patient
characteristics, and serious and non-serious outcome groups
were compared using Fisher’s exact test (table 2).
RESULTS
Ninety-nine consecutive adult patients were recruited over a 3-
month period between 7 November 2005 and 7 February 2006.
It was thought that 100 patients had been enrolled; however,
one patient episode had been erroneously duplicated during
data entry. In all, 44 patients were admitted to the hospital and
55 were discharged from the ED. Of the 11 patients with a
serious outcome, 8 had developed this by 7 days and 3 further
patients had developed a serious outcome by 3 months. In all,
therefore, 11 patients had a serious outcome by 3 months. Of
these, five patients died and six had an alternative serious
outcome. All 11 had been admitted to hospital from the ED. The
percentage risk of serious outcome at 7 days, 1 month and
3 months was 8.1%, 8.1% and 11.1%, respectively.
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Figure 1 The number of patients from each emergency department (ED)
guidelines risk group for serious and not serious 3-month outcomes, and
percentage of serious outcome for each ED guidelines risk group.
Figure 2 Graph showing number of patients with each Osservatorio
Epidemiologico sulla Sincope nel Lazio (OESIL) score for serious and not
serious 3-month outcomes, and percentage of serious outcome for each
OESIL score.
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Current ED guidelines
In all, 32 patients were at high risk, 51 at medium risk and 16 at
low risk according to our existing ED guidelines. Of the patients
with a serious outcome, seven were at high risk, four were at
medium risk and none was at low risk. A total of 7 of 32 (22%)
high-risk patients, 4 of 51 (8%) medium-risk patients and 0 of
16 (0%) low-risk patients had a serious outcome (fig 1). In all,
19 of the 51 medium-risk patients were admitted to hospital
and no patient with a subsequent serious outcome was
discharged directly from the ED. Admission of all high-risk
patients only (by ED guidelines) would have led to 12 fewer
admissions; however, 4 patients with serious outcomes would
have been discharged. Admission of all medium- and high-risk
patients only would have led to 39 further admissions but
would have detected all patients with serious outcomes.
OESIL score
A total of 10 patients had an OESIL score of 0 (no serious
outcomes), 34 had an OESIL score of 1 (1 serious outcome), 25
had an OESIL score of 2 (2 serious outcomes), 22 had an OESIL
score of 3 (5 serious outcomes) and 8 patients had an OESIL
score of 4, of which 3 had a serious outcome (fig 2).
Percentages of serious outcomes were 0%, 2.9%, 8%, 22.7%
and 37.5% for OESIL scores of 0, 1, 2, 3 and 4, respectively
(fig 2). This compares with 0%, 0.8%, 19.6%, 34.7% and 57.1%
for 12-month mortality in Colivicchi et al’s13 paper. Use of the
OESIL score with a cut-off for admission of an .0 instead of
existing guidelines would have led to 55 further admissions,
with no patients having serious outcomes being discharged. An
OESIL score .1 would have led to 11 further admissions, with
1 patient having a serious outcome being discharged. An OESIL
score .2 would have led to 14 fewer admissions, with 3
patients having serious outcomes being discharged and an
OESIL score .3 would have led to 36 fewer admissions, with 8
patients having serious outcomes being discharged.
San Francisco Syncope Rule
A total of 40 patients had none of the 5 SFSR risk factors
(with no serious outcomes = 0%) and 59 patients had an SFSR
high-risk factor present (11 serious outcomes = 18.6%; fig 3).
Use of the SFSR instead of existing guidelines would have led
to 15 further admissions, with no improvement in sensitivity on
current practice in our ED.
Study pick-up rate and comparison of study group and
‘‘missed’’ group
A total of 263 patients presenting between 7 November 2005
and 7 February 2006 were identified from the EPR search as
fitting the study’s inclusion criteria. The study therefore
managed to pick up 37.6% of patients eligible for inclusion.
There were 74 men (45%) and 90 women in the ‘‘missed group’’
compared with 48 men (48%) and 51 women in the ‘‘study
group’’ (p = 0.6, NS, x2 test). Neither the ages of the study
group nor of the missed group were normally distributed. The
median age of the study group was 71 years (interquartile
range (IQR) 47–81) and that of the missed group was
62.5 years (IQR 29–78; p = 0.047, significant at the 5% level,
Mann–Whitney U test).
DISCUSSION
This study was conducted as a pilot for the ROSE study. It is the
first prospective study on syncope within UK ED practice and
the first attempt to evaluate existing clinical decision rules in
the UK. The primary aim of the study was to assess the process
of patient recruitment and to test the study method and
feasibility of data collection before the main ROSE study.
A power calculation was not performed before the pilot, and
we acknowledge that the study did not enrol a cohort of
patients large enough to derive a clinical decision rule, one of
the aims of the main ROSE study. The secondary aim of the
study was to compare the performance of our current ED
guidelines with the OESIL score and the SFSR at predicting
short- and medium-term serious outcomes. Again, because of
the small size of the study, we have only conducted a statistical
analysis of serious outcome at 3 months. The findings of this
pilot study, although requiring cautious interpretation, are
important.
This study only recruited 37.6% of eligible patients.
Conducting ED research such as this is difficult; however, the
recruitment rate will need to be improved for the main study.
Closer analysis reveals that the ‘‘missed’’ group had a lower
median age than the ‘‘study’’ group and that the distribution of
risk groups in the ‘‘study’’ group is skewed towards the more
serious end of the scale. This suggests that the treating doctors
were not enrolling younger patients with simple low-risk
vasovagal faints. This has probably led to a higher serious
outcome rate. If this is repeated in the main study, it may mean
that any derived clinical rule may not be applicable to this
group, albeit a low-risk one. This problem must therefore be
addressed in the main study by further training of recruiters
and an improved method of picking up all eligible patients.
Using a 7-day event rate of 10%, a power calculation
performed to determine sample size requirements for a large
prospective derivation and a validation study suggested that
500 patients would need to be recruited into a derivation cohort
and 500 into a validation cohort. With improvements in our
recruitment processes, we estimate that this is feasible over
2 years.
There are few studies on syncope based on in UK EDs. In
1999 Thakore et al17 looked at practice in one UK ED and
showed that few patients had relevant syncope symptoms
documented or an ECG recorded. In all, 28% of patients with an
abnormal ECG and 40% with a history of organic heart disease
were sent home from the ED. Prior to our study, the only UK
ED study of syncope outcome was conducted by Crane.18 This
retrospective study of 210 patients presenting during an 8-week
Figure 3 The number of patients with each San Francisco Syncope Rule
(SFSR) risk group for serious and not serious 3-month outcomes, and
percentage of serious outcome for each SFSR risk group.
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period showed that it was possible to stratify UK ED patients
with syncope according to ACP guidelines.6 7 Patients in ACP
group 1 (high risk) had a 1-year mortality of 36%, compared
with patients assigned to ACP group 2 (intermediate risk; 14%)
and to ACP group 3 (low risk; 0%). Our study confirms the
findings of Crane, showing that our ED guidelines (based on
the European Society of Cardiology,9 10 ACP6 7 and the American
College of Emergency Physician guidelines8) can successfully
risk stratify UK ED patients with syncope.
Following our existing ED guidelines and making a decision
to admit a high-risk patient with a ‘‘high-risk’’ factor led to a
reasonable sensitivity (0.636) and good specificity (0.716) for
serious outcome. Considering admission for all medium- and
high-risk patients ensures that no serious outcomes are missed;
however, this would lead to a large increase in admissions for
only a small increase in the detection of patients with serious
outcomes. Despite our guidelines suggesting that medium-risk
patients could be considered for discharge to outpatient review,
19 of the 51 medium-risk patients were admitted to hospital
and no patients with serious outcomes were discharged. This
suggests that the doctor’s judgement may have played an
important part in deciding which medium-risk patients may
have been at increased risk. If they have not already, all UK EDs
should have similar guidelines in place in order to effectively
risk stratify patients presenting with syncope.
The OESIL score was originally derived and validated to
predict 12-month all-cause mortality. It differs from the SFSR
in that the original study demonstrated that an increasing
OESIL score is associated with an increased risk of a serious
outcome, whereas the SFSR relies only on the presence of one
of five high-risk factors. Our study findings are similar to those
of the original study; however, where to place the cut-off for
admission to hospital is unclear and was not defined in the
original study. Admitting patients who have an OESIL score .1
has the required sensitivity, but would have led to 11 more
admissions. Setting a higher cut-off is associated with an
improved specificity at the expense of a reduced sensitivity.
The SFSR was originally devised to predict a 7-day serious
outcome. Again, our study findings are similar to the results of
the original study, the SFSR showing a sensitivity of 1 and a
specificity of 0.455. Adopting this rule, however, would have led
to 15 more admissions with the detection of no more serious
outcomes. This suggests that although the SFSR may be a
sensitive tool in the UK ED population, its use would increase
admissions with only a small increase in the detection of
patients with serious outcome. It is interesting that the OESIL
risk factor ‘‘age.65’’ alone performs better than both the SFSR
and our existing ED guidelines.
Clearly, there is a need for a large prospective study of syncope in
the UK ED population. Existing CDRs show some promise;
however, there is room to improve these tools. There are large
differences in practice and admission policies between UK and
North American EDs and therefore there is a definite need to derive
and validate a more useful tool for use in the UK population.
Despite this being costly and time consuming its potential benefits
are many, including reducing unwarranted admissions, improving
patient outcome and satisfaction and allowing resources to be
concentrated on patients most at risk of adverse events.
CONCLUSION
This pilot demonstrates that a study to derive and validate an
ED syncope stratification rule is feasible. The pilot also enabled
the study method and data collection process to be assessed and
revised before starting the main ROSE study.
This study has evaluated the OESIL score, the SFSR and our
existing ED guidelines, and has shown that each is able to
identify an increased probability of medium-term serious
outcome in patients with syncope despite the OESIL score
being initially derived and validated for long-term prediction
and the SFSR for short-term outcome. The SFSR shows good
sensitivity at the expense of an increase in admissions to
hospital; however, our existing ED syncope guidelines and the
OESIL score, although being able to successfully risk stratify
patients, are not sufficiently sensitive to be able to reduce
admissions without missing patients who later go on to develop
a serious outcome.
Undoubtedly, there is a need for a simple UK-derived clinical
decision rule for patients presenting with syncope to enable safe,
effective clinical care and to aid less experienced decision makers.
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OESIL .2 0.267 0.957 0.727 0.750 2.909 0.364 0.003*
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